Genzyme Corp. (NASDAQ: GENZ) today announced that the results from its Late-Onset Treatment Study have been published in today’s New ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE